Chapter 2 Summary and Highlights
Chapter 3 Market Overview and Technology Background
- Overview
- Gene Addition or Augmentation
- Gene Correction
- Gene Silencing
- Manufacturing
- Supply Chain
- Regulatory Landscape
- U.S. (FDA)
- Europe
- Outsourcing of Manufacturing
Chapter 4 Market Dynamics
- Factors Affecting the Market
- Market Drivers
- Increasing Investment and Funding for CGT Development
- Capacity Expansions for Clinical and Commercial Manufacturing
- Rising Prevalence of Chronic Diseases and Focus on Rare Diseases
- Increasing Strategic Collaborations and Acquisitions
- Market Restraints
- Complex Manufacturing and Supply Chain
- Lack of Skilled Workforce
- Regulatory Hurdles
- Market Opportunities
Chapter 5 Emerging Technologies
- Introduction
- Emerging Technologies
- Automation
- Digitalization
- Single-Use Technologies
- Emerging Manufacturing Models
Chapter 6 Market Breakdown by Type
- Overview
- Cell Therapy
- Gene Therapy
- Cell Therapy Types
- Autologous Cell Therapy
- Allogeneic Cell Therapy
- Cell and Gene Therapy Types Based on Vector Type
- Viral Vectors
- Nonviral Vectors
Chapter 7 Market Breakdown by Application
- Overview
- Clinical Manufacturing
- Commercial Scale Manufacturing
Chapter 8 Market Breakdown by Disease
- Overview
- Cancer
- Rare Diseases
- Other Diseases
Chapter 9 Market Breakdown by End User
- Overview
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Chapter 10 Market Breakdown by Region
- Overview
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- Rest of Asia-Pacific
- Rest of the World
Chapter 11 Sustainability: An ESG Perspective
- Overview
- ESG Practices in the CGT Manufacturing Industry
- Case Studies: Examples of Successful ESG Implementation
- Conclusion
Chapter 12 M&A, Funding Outlook and Competitive Landscape
- Investments Outlook
- Mergers and Acquisitions
- Strategic Initiatives
- Competitive Analysis
Chapter 13 Company Profiles
- CATALENT INC.
- CELL AND GENE THERAPY CATAPULT
- CHARLES RIVER LABORATORIES
- FUJIFILM DIOSYNTH BIOTECHNOLOGIES
- LONZA GROUP AG
- MERCK KGAA
- MILTENYI BIOTEC
- NIKON CELL INNOVATION CO. LTD.
- TAKARA BIO INC.
- THERMO FISHER SCIENTIFIC
- WUXI ADVANCED THERAPIES
List of Tables
Summary Table A: Global Market for Cell and Gene Therapy Manufacturing Services, Through 2028
Summary Table B: Global Market for Cell and Gene Therapy Manufacturing Services, by Region, Through 2028
Table 1: Global Cancer Statistics, 2020
Table 2: Global Market for Cell and Gene Therapy Manufacturing Services, by Type, Through 2028
Table 3: Global Market for Cell Therapy Manufacturing Services, by Region, Through 2028
Table 4: Global Market for Gene Therapy Manufacturing Services, by Region, Through 2028
Table 5: Global Market for Cell Therapy Manufacturing Services, by Type, Through 2028
Table 6: Global Market for Autologous Cell Therapy Manufacturing Services, by Region, Through 2028
Table 7: Global Market for Allogeneic Cell Therapy Manufacturing Services, by Region, Through 2028
Table 8: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services, by Vector, Through 2028
Table 9: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services for Viral Vectors, by Region, Through 2028
Table 10: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services for Nonviral Vectors, by Region, Through 2028
Table 11: Global Market for Cell and Gene Therapy Manufacturing Services, by Application, Through 2028
Table 12: Global Market for Clinical Cell and Gene Therapy Manufacturing Services, by Region, Through 2028
Table 13: Global Market for Commercial Cell and Gene Therapy Manufacturing Services, by Region, Through 2028
Table 14: Global Market for Cell and Gene Therapy Manufacturing Services, by Disease, Through 2028
Table 15: Global Market for Cell and Gene Therapy Manufacturing Services for Cancer, by Region, Through 2028
Table 16: Global Market for Cell and Gene Therapy Manufacturing Services for Rare Diseases, by Region, Through 2028
Table 17: Global Market for Cell and Gene Therapy Manufacturing Services for Other Diseases, by Region, Through 2028
Table 18: Global Market for Cell and Gene Therapy Manufacturing Services, by End User, Through 2028
Table 19: Global Market for Cell and Gene Therapy Manufacturing Services for Pharmaceutical and Biotechnology Companies, by Region, Through 2028
Table 20: Global Market for Cell and Gene Therapy Manufacturing Services for Academic and Research Institutes, by Region, Through 2028
Table 21: Global Market for Cell and Gene Therapy Manufacturing Services for Other End Users, by Region, Through 2028
Table 22: Global Market for Cell and Gene Therapy Manufacturing Services, by Region, Through 2028
Table 23: North American Market for Cell and Gene Therapy Manufacturing Services, by Country, Through 2028
Table 24: European Market for Cell and Gene Therapy Manufacturing Services, by Country, Through 2028
Table 25: Asia-Pacific Market for Cell and Gene Therapy Manufacturing Services, by Country, Through 2028
Table 26: ESG Rating/Metric
Table 27: Environmental Initiatives by Various CGT Manufacturing CDMOs/Companies
Table 28: ESG Rankings for Companies in the CGT Manufacturing Services Market, 2023
Table 29: Mergers and Acquisitions, 2020-2022
Table 30: Catalent: Financials,2022
Table 31: Catalent: News
Table 32: Charles River Laboratories: Financials, 2022
Table 33: Charles River Laboratories: News
Table 34: Charles River Laboratories: Cell and Gene Manufacturing Services Offerings
Table 35: FUJIFILM Diosynth Biotechnologies: Financials, 2022
Table 36: FUJIFILM Diosynth Biotechnologies: News
Table 37: Lonza: Financials, 2022
Table 38: Lonza: News
Table 39: Lonza: Cell and Gene Services Offerings
Table 40: Merck KGaA: Financials, 2022
Table 41: Merck KGaA: Cell and Gene Manufacturing Services Offerings
Table 42: Merck KGaA: News
Table 43: Takara Bio: Financials, 2022
Table 44: Takara Bio: Cell and Gene Services Offerings
Table 45: Takara Bio.: News
Table 46: Thermo Fisher Scientific Inc: Financials, 2022
Table 47: Thermo Fisher: Cell and Gene Services Offerings
Table 48: Thermo Fisher Scientific Inc.: News
Table 49: WuXi Advanced Therapies: Financials, 2022
Table 50: WuXi Advanced Therapies: News
List of Figures
Summary Figure A: Global Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Summary Figure B: Global Market for Cell and Gene Therapy Manufacturing Services, by Region, 2020-2028
Figure 1: Cell Therapy Manufacturing Process
Figure 2: Pharmaceutical Products - Supply Chain
Figure 3: Cell Therapy Products - Supply Chain
Figure 4: Cell Therapy Products - Regulatory Pathway
Figure 5: Centralized Manufacturing Model
Figure 6: Decentralized Manufacturing Model
Figure 7: Global Market for Cell and Gene Therapy Manufacturing Services, by Type, 2020-2028
Figure 8: Global Market Shares of Cell and Gene Therapy Manufacturing Services, by Type, 2022
Figure 9: Global Market for Cell Therapy Manufacturing Services, by Region, 2020-2028
Figure 10: Global Market for Gene Therapy Manufacturing Services, by Region, 2020-2028
Figure 11: Types of Cell Therapies
Figure 12: Advantages and Disadvantages of Cell Therapy Types
Figure 13: Global Market for Cell Therapy Manufacturing Services, by Type, 2020-2028
Figure 14: Global Market for Autologous Cell Therapy Manufacturing Services, by Region, 2020-2028
Figure 15: Global Market for Allogeneic Cell Therapy Manufacturing Services, by Region, 2020-2028
Figure 16: Shares of Vectors Used in Clinical Trials on Gene Therapy, 2022
Figure 17: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services, by Vector, 2020-2028
Figure 18: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services for Viral Vectors, by Region, 2020-2028
Figure 19: Global Market for Gene-Modified Cell and Gene Therapy Manufacturing Services for Nonviral Vectors, by Region, 2020-2028
Figure 20: Global Market for Cell and Gene Therapy Manufacturing Services, by Application, 2020-2028
Figure 21: Global Market Shares of Cell and Gene Therapy Manufacturing Services, by Application, 2022
Figure 22: CGT Clinical Pipeline, by Phase and Type
Figure 23: Global Market for Clinical Cell and Gene Therapy Manufacturing Services, by Region, 2020-2028
Figure 24: Global Market for Commercial Cell and Gene Therapy Manufacturing Services, by Region, 2020-2028
Figure 25: Global Market for Cell and Gene Therapy Manufacturing Services, by Disease, 2020-2028
Figure 26: Global Market Shares of Cell and Gene Therapy Manufacturing Services, by Disease, 2022
Figure 27: CGT Oncology Pipeline, by Phase and Type
Figure 28: Global Market for Cell and Gene Therapy Manufacturing Services for Cancer, by Region, 2020-2028
Figure 29: Global Market for Cell and Gene Therapy Manufacturing Services for Rare Diseases, by Region, 2020-2028
Figure 30: Global Market for Cell and Gene Therapy Manufacturing Services for Other Diseases, by Region, 2020-2028
Figure 31: Global Market for Cell and Gene Therapy Manufacturing Services, by End User, 2020-2028
Figure 32: Global Market Shares of Cell and Gene Therapy Manufacturing Services, by End User, 2022
Figure 33: Global Market for Cell and Gene Therapy Manufacturing Services for Pharmaceutical and Biotechnology Companies, by Region, 2020-2028
Figure 34: CGT Clinical Pipeline, by Sponsor
Figure 35: Global Market for Cell and Gene Therapy Manufacturing Services for Academic and Research Institutes, by Region, 2020-2028
Figure 36: Global Market for Cell and Gene Therapy Manufacturing Services for Other End Users, by Region, 2020-2028
Figure 37: Global Market for Cell and Gene Therapy Manufacturing Services, by Region, 2020-2028
Figure 38: Global Market Shares of Cell and Gene Therapy Manufacturing Services, by Region, 2022
Figure 39: North American Market for Cell and Gene Therapy Manufacturing Services, by Country, 2020-2028
Figure 40: U.S. Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 41: Canadian Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 42: European Market for Cell and Gene Therapy Manufacturing Services, by Country, 2020-2028
Figure 43: U.K. Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 44: German Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 45: French Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 46: Rest of European Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 47: Asia-Pacific Market for Cell and Gene Therapy Manufacturing Services, by Country, 2020-2028
Figure 48: Chinese Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 49: Japanese Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 50: Australian Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 51: Rest of APAC Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 52: Rest of the World Market for Cell and Gene Therapy Manufacturing Services, 2020-2028
Figure 53: ESG in CGT Manufacturing Industry
Figure 54: Investments, by Year, 2017-2022
Figure 55: Equity Offering and Venture Financing, 2021 and 2022
Figure 56: Public and Private Companies Deal Value, 2021 and 2022
Figure 57: Number of Deals, 2021 and 2022
Figure 58: M&A Deals, 2021 and 2022
Figure 59: Strategic Alliance Deals, 2021 and 2022
Figure 60: Global Market Shares of CGT Manufacturing Services, by Manufacturer, 2022
Figure 61: Catalent: Financials, 2021 and 2022
Figure 62: Catalent: Market Share, by Business Segment, 2022
Figure 63: Charles River Laboratories: Financials, 2021 and 2022
Figure 64: Charles River Laboratories: Market Share, by Business Segment, 2022
Figure 65: Charles River Laboratories: Revenue Share, by Region/Country, 2022
Figure 66: FUJIFILM Diosynth Biotechnologies: Financials, 2021 and 2022
Figure 67: Lonza: Financials, 2021 and 2022
Figure 68: Lonza: Market Share, by Business Segment, 2022
Figure 69: Lonza: Revenue Share, by Region/Country, 2022
Figure 70: Merck KGaA: Financials, 2021 and 2022
Figure 71: Merck KGaA Life Sciences: Market Share, by Region, 2022
Figure 72: Merck KGaA Life Sciences: Market Share, by Business Segment, 2022
Figure 73: Takara Bio: Financials, 2021 and 2022
Figure 74: Takara Bio.: Market Share, by Region, 2022
Figure 75: Takara Bio.: Market Share, by Business Segment, 2022
Figure 76: Thermo Fisher Scientific Financials, 2021 and 2022
Figure 77: Thermo Fisher Scientific Inc.: Market Share, by Region, 2022
Figure 78: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
Figure 79: WuXi Advanced Therapies: Annual Revenue, 2021 and 2022
